Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The US FDA’s Nifty Fifty

23 Dec 2020

• By Michael McCaughan

50 celebration balloons and confetti (shutterstock_1663645954) — • Source: Shutterstock

Related Content

US FDA Ends 2019 With Second-Highest Approval Count After Second-Half Rebound

02 Jan 2020

Firms That Get Complete Response Letters Might Get Inspected By US FDA Six Months After Replies

23 Dec 2020

Moderna’s Stronger Vaccine AdComm Vote Indicative Of Second Mover Advantage, Not Data Profile

18 Dec 2020

Related Companies

MacroGenics, Inc.

Additional Topics

United States Approvals Coronavirus COVID-19 Drug Review FDA Regulation BioPharmaceutical

More from Approvals

More from Product Reviews

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.